Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genetic Technologies
Fitzroy, Victoria, Australiagenetictechnologies.com ↗
- Ownership
- Public · GENE
- Employees
- ~55
- Development stage
- Commercial
01
Overview
Genetic Technologies has developed and commercialized a suite of clinically validated, non-invasive saliva-based tests that assess individual risks for multiple serious diseases using integrated polygenic risk scores. Their flagship product line "geneType" covers nine major conditions including several cancers and chronic diseases. The tests are regulatory approved and used in both Australia and North America. The company continues to expand its portfolio with new indications under development.
- Therapeutic areas
- OncologyEndocrinologyCardiovascular
- Modalities
- Diagnostic testGenomic risk assessmentPolygenic risk score
- Industry
- Molecular Diagnostics
02
Partnerships
Rhythm Biosciences – acquired select Genetype business assets related to colorectal testing in December 2024.GCPH – agreement to establish a precision medicine clinic at a hospital in September 2023.Collaborations with healthcare systems, research institutions globally.
03
Financials
- Market cap
- $111.2M
- Total revenue
- $4.8M
- Enterprise value
- $111.1M
Beyond the preview
Go deeper on Genetic Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genetic Technologies.